What to watch with hsCRP and Langlebigkeit?

hsCRP (high-sensitivity C-reactive protein) is a well-established biomarker of systemic inflammation. Numerous observational studies show that elevated hsCRP levels (>2–3 mg/L) are associated with increased risk of cardiovascular disease and premature mortality – hence the link to longevity. However, hsCRP is not a direct causal factor but a risk marker influenced by many variables: acute infections, smoking, obesity, poor sleep, or chronic inflammatory conditions. A single elevated reading says little about individual life expectancy. Consumer tests like MyBody-X typically measure hsCRP reliably, but interpretation should always consider other risk factors and medical advice. The evidence level is 'human-moderate', based on large epidemiological studies, but no randomized controlled trials have proven that lowering hsCRP alone extends lifespan. For longevity, a low, stable hsCRP level (<1 mg/L) is favorable, but it is only one piece of the puzzle alongside genetics, lifestyle, and environment. Caveat: acute inflammation or medications (e.g., statins) can skew results.